Plasma cortisol and norepinephrine in Alzheimer's disease: Opposite relations with recall performance and stage of progression

Acta Neuropsychiatrica

Volumn 19, Issue 4, 2007, Pages 231-237

  Bemelmans, Karel J ^a   Noort, Annemarie ^b   De Rijk, Roel ^c,d   Middelkoop, Huub A M ^d   Van Kempen, Godfried M J ^d   Goekoop, Jaap G ^a,d  

^a GGZ Leiden   (Netherlands)

^b De Stichting 'Meerkanten'   (Netherlands)

^c LEIDEN UNIVERSITY   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer's disease; Plasma cortisol; Plasma norepinephrine; Recall performance; Stage of progression

Indexed keywords

HYDROCORTISONE; NORADRENALIN;

AGED; ALZHEIMER DISEASE; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; MALE; NORADRENALIN BLOOD LEVEL; RATING SCALE; RECALL; SCORING SYSTEM;

EID: 34447634147     PISSN: 09242708     EISSN: 16015215     Source Type: Journal    
DOI: 10.1111/j.1601-5215.2006.00172.x     Document Type: Article

References (41)

1. Hodges J. The amnestic prodrome of Alzheimer's disease. Brain 1998 121: 1601 1602.
2. Bayley PJ, Salmon DP, Bond MW, Bui BK, Olichney J, Delis DC. Comparison of the serial position effect in very mild Alzheimer's disease, mild Alzheimer's disease, and amnesia associated with electroconvulsive therapy. J Int Neuropsychol Soc 2000 6: 290 298.
3. Bemelmans KJ, Goekoop JG. The contribution of list length to the absence of the primacy effect in word recall in dementia of the Alzheimer type. Psychol Med 1991 21: 1047 1053.
4. Foldi NS, Brickman AM, Schaefer LA, Knutelska ME. Distinct serial position profiles and neuropsychological measures differentiate late life depression from normal aging and Alzheimer's disease. Psychiatry Res 2003 120: 71 84.
5. Gianotti G, Marra C, Villa G, Parlato V, Chiarotti E. Sensitivity and specificity of some neuropsychological markers of Alzheimer's dementia. Alzheimer Dis Assoc Disord 1998 12:152 162.
6. Hasher L, Zacks RT. Automatic and effortful processing in memory. J Exp Psychol Gen 1979 108:356 388.
7. Kesner RP, Measom MO, Forsman SL, Holbrook TH. Serial position curves in rats: order memory for episodic spatial events. Animal Learn Behav 1984 12:378 382.
8. Hermann BP, Seidenberg M, Wyler A et al. The effects of hippocampal resection on the serial position curve. Cortex 1996 32:323 334.
9. Pomara N, Greenberg WM, Branford MD, Doraiswamy PM. Therapeutic implications of HPA axis abnormalities in Alzheimer's disease: review and update. Psychopharmacol Bull 2003 37:120 134.
10. Raskind MA, Peskind ER, Holmes C, Goldstein DS. Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and Alzheimer's disease. Biol Psychiatry 1999 46:756 765.
11. Elrod R, Peskind ER, Digiacomo L, Brodkin KI, Veith RC, Raskind MA. Effects of Alzheimer's disease severity on cerebrospinal fluid norepinephrine concentration. Am J Psychiatry 1997 154:25 30.
12. Sapolsky RM, Krey LC, McEwen BS. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr Rev 1986 7:284 301.
13. O'Brien JT, Ames D, Schweitzer I. HPA axis function in depression and dementia: a review. Int J Geriatr Psychiatry 1993 8:887 898.
14. Swaab DF, Bao AM, Lucassen PJ. The stress system in the human brain in depression and neurodegeneration. Ageing Res Rev 2005 4:141 194.
15. Fuchs E, Flugge G, Czeh B. Remodeling of neuronal networks by stress. Front Biosci 2006 11:2746 2758.
16. Miller AH, Sastry G, Speranza AJ et al. Lack of association between cortisol hypersecretion and nonsuppression on the DST in patients with Alzheimer's disease. Am J Psychiatry 1994 151:267 270.
17. Buchanan TW, Kern S, Allen JS, Tranel D, Kirschbaum C. Circadian regulation of cortisol after hippocampal damage in humans. Biol Psychiatry 2004 56:651 656.
18. Herrmann N, Lanctôt KL, Khan LR. The role of norepinephrine in the behavioral and psychological symptoms of dementia. J Neuropsychiatry Clin Neurosci 2004 16:261 267.
19. Bondareff W, Mountjoy CQ, Roth M. Loss of neurons of the origin of the adrenergic projection to the cerebral cortex (nucleus locus ceruleus) in senile dementia. Neurology 1982 32:1164 1168.
20. Acheson AL, Zigmond MJ. Short and long-term changes in tyrosine-hydroxylase activity in rat-brain after subtotal destruction of central noradrenergic neurons. J Neurosci 1981 1:493 504.
21. Hoogendijk WJ, Feenstra MG, Botterblom MH et al. Increased activity of surviving locus ceruleus neurons in Alzheimer's disease. Ann Neurol 1999 45:82 91.
22. Lawlor BA, Bierer LM, Ryan TM et al. Plasma 3-methoxy-4- hydroxyphenylglycol (MHPG) and clinical symptoms in Alzheimer's disease. Biol Psychiatry 1995 38:185 188.
23. Robbins TW, Everitt BJ. Central norepinephrine neurons and behaviour. In:Bloom FE, Kupfer DJ, eds. Psychopharmacology, the fourth generation of progress. New York:Raven, 1995:363 372.
24. Ziegler MG, Lake CR, Wood JH, Brooks BR, Ebert MH. Relationship between norepinephrine in blood and cerebral spinal fluid in the presence of a blood-cerebrospinal fluid barrier for norepinephrine. J Neurochem 1977 28:677 679.
25. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edn, Washington, DC:American Psychiatric Association, 1994.
26. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new scale for staging of dementia. Br J Psychiatry 1982 140:566 572.
27. Tunn S, Mollmann H, Barth J, Derendorf H, Krieg M. Simultaneous measurement of cortisol in serum and saliva after different forms of cortisol administration. Clin Chem 1992 38:1491 1494.
28. Javidan S, Cwik MJ. Determination of catecholamines in human plasma by HPLC with electrochemical detection. J Liq Chromotogr Relat Technol 1996 19:1339 1348.
29. Rey A. L'Examen Clinique en Psychology. Paris:Presses Universitaires de France, 1964.
30. Bemelmans KJ, Wolters G, Zwinderman AH, Ten Berge JMF, Goekoop JG. Evidence for two processes underlying the serial position curve of single & multi- trial free-recall in a heterogeneous group of psychiatric patients: a confirmatory factor analytic study. Memory 2002 10:151 160.
31. Bemelmans KJ, Goekoop JG, de Rijk R, van Kempen GMJ. Recall performance and plasma cortisol and plasma norepinephrine in normal human subjects. Biol Psychol 2003 62:1 15.
32. Schneider W, Shiffrin RM. Controlled and automatic information processing I: detection, search and attention. Psychol Rev 1977 84:1 66.
33. Bemelmans KJ, Goekoop JG, van Kempen GMJ. Recall performance in acutely depressed patients and plasma cortisol. Biol Psychiatry 1996 39:750 752.
34. Diamond DM, Bennett MC, Fleshner M, Rose GM. Inverted-U relationship between the level of peripheral corticosterone and the magnitude of hippocampal prime burst potentiation. Hippocampus 1992 2:421 430.
35. Weil-Malherbe H, Axelrod J, Tomchick R. Blood brain barrier for adrenaline. Science 1998 12:1226 1227.
36. Clark KB, Naritoku DK, Smith DC, Browning RA, Jensen RA. Enhanced recognition memory following vagus nerve stimulation in human subjects. Nat Neurosci 1999 2:94 98.
37. Sjogren MJ, Hellstrom PT, Jonsson MA, Runnerstam M, Silander HC, Ben-Menachem E. Cognition-enhancing effect of vagus nerve stimulation in patients with Alzheimer's disease: a pilot study. J Clin Psychiatry 2002 63:972 980.
38. Southwick SM, Davis M, Horner B et al. Relationship of enhanced norepinephrine activity during memory consolidation to enhanced long-term memory in humans. Am J Psychiatry 2002 159:1420 1422.
39. O'Carroll RE, Drysdale E, Cahill L, Shajahan P, Ebmeier KP. Stimulation of the noradrenergic system enhances and blockade reduces memory for emotional material in man. Psychol Med 1999 29:1083 1088.
40. Kalmijn S, Launer LJ, Stolk RP et al. A prospective study on cortisol, dehydroepiandrosterone sulfate, and cognitive function in the elderly. J Clin Endocrinol Metab 1998 83:3487 3492.
41. Seeman TE, McEwen BS, Singer BH, Albert MS, Rowe JW. Increase in urinary cortisol excretion and memory declines: MacArthur studies of successful aging. J Clin Endocrinol Metab 1997 8:2458 2465.